TRFIA检测胃蛋白酶原在溃疡型胃癌筛查中的价值

doi:10.3969/j.issn.1673-8640.2020.07.021

摘要/Abstract

摘要：

目的探讨时间分辨荧光分析法（TRFIA）检测血浆胃蛋白酶原（PG）Ⅰ、PGⅡ和胃蛋白酶原Ⅰ/胃蛋白酶原Ⅱ比值（PGR）在溃疡型胃癌筛查中的价值。方法选取行胃镜检查的患者547例,根据胃镜和病理检查结果分为非萎缩性胃炎72例、非萎缩性胃炎伴有其他病理病变232例、萎缩性胃炎42例、消化性溃疡82例、上皮内瘤变15例、胃癌104例（溃疡型胃癌43例,其他型胃癌61例）。采用TRFIA和化学发光微粒子免疫分析法（CMIA）分别检测其中447名胃病患者血浆PGⅠ、PGⅡ水平,并计算PGR值。采用受试者工作特征（ROC）曲线评价PGR诊断溃疡型胃癌的效能。结果 TRFIA与CMIA检测PGⅠ和PGⅡ的结果均呈正相关（r值分别为0.894、0.982,P<0.05）。TRFIA与CMIA检测PGⅠ高值（TRFIA检测PGⅠ的结果≥240 ng/mL）样本的一致性较差。与消化性溃疡组比较,胃癌组血浆PGⅠ水平及PGR显著降低（P<0.05）,溃疡型胃癌组PGR显著降低（P<0.05）,其他型胃癌组血浆PGⅠ水平显著降低（P<0.05）。溃疡型胃癌组血浆PGⅡ水平及PGR显著高于其他型胃癌组（P<0.05）。PGR诊断溃疡型胃癌的曲线下面积（AUC）为0.711,最佳临界值为18.20,敏感性为72.1%,特异性为70.8%;诊断胃癌的AUC为0.797,最佳临界值为18.37,敏感性为79.8%,特异性为70.8%。结论 TRFIA与CMIA检测PGⅠ、PGⅡ的结果相关性较好,TRFIA检测上限高于CMIA。PGR对溃疡型胃癌有一定的诊断价值。

关键词: 胃蛋白酶原Ⅰ, 胃蛋白酶原Ⅱ, 胃蛋白酶原Ⅰ/胃蛋白酶原Ⅱ比值, 时间分辨荧光分析法, 溃疡型胃癌, 胃癌

Abstract:

Objective To investigate the role of time-resolved fluoroimmunoassay（TRFIA） for detecting plasma pepsinogen（PG） Ⅰ,PGⅡ and pepsinogen Ⅰ/pepsinogen Ⅱ ratio（PGR） in screening ulcer gastric cancer. Methods According to the results of gastroscopy and pathology,547 patients were classified into 72 cases of non-atrophic gastritis,232 cases of non-atrophic gastritis with other pathology,42 cases of atrophic gastritis,82 cases of peptic ulcer,15 cases of intraepithelial neoplasia and 104 cases of gastric cancer [43 cases of ulcer gastric cancer（ulcer gastric cancer group） and 61 cases of other gastric cancers（other gastric cancer group）]. TRFIA and chemiluminescence microparticle immunoassay（CMIA） were used to detect plasma PGⅠ and PGⅡ levels of 447 patients with gastric diseases,and PGR was calculated. Receiver operating characteristic（ROC） curve was used to evaluate the efficiency of PGR in the diagnosis of ulcer gastric cancer. Results The results of PGⅠ and PGⅡ of TRFIA and CMIA were positively correlated（r=0.894 and 0.982,P<0.05）. The results of TRFIA for samples with PGⅠ≥240 ng/mL had poor consistency with CMIA. Compared with peptic ulcer group,plasma PGⅠ level and PGR in gastric cancer group were decreased（P<0.05）,and PGR in ulcer gastric cancer group was decreased（P<0.05）,and plasma PGⅠ level in other gastric cancer group was decreased（P<0.05）. Plasma PGⅡ level and PGR of ulcer gastric cancer group were higher than those of other gastric cancer group（P<0.05）. The area under curve（AUC） of PGR for the diagnosis of ulcer gastric cancer was 0.711. The optimal cut-off value was 18.20,the sensitivity was 72.1%,and the specificity was 70.8%. The AUC for the diagnosis of gastric cancer was 0.797,the optimal cut-off value was 18.37,the sensitivity was 79.8%,and the specificity was 70.8%. Conclusions PG Ⅰ and PG Ⅱ detections by TRFIA have a good correlation with CMIA. The upper detection limit of TRFIA is better than that of CMIA. PGR has certain diagnostic value for ulcer gastric cancer.

Key words: Pepsinogen Ⅰ, Pepsinogen Ⅱ, Pepsinogen Ⅰ/pepsinogen Ⅱ ratio, Time-resolved fluoroimmunoassay, Ulcer gastric cancer, Gastric cancer

中图分类号:

R446.1

杭晨, 黄飚, 彭海霞, 韦欣, 徐伟红, 盛慧明, 李宁丽. TRFIA检测胃蛋白酶原在溃疡型胃癌筛查中的价值[J]. 检验医学, 2020, 35(7): 721-725.

HANG Chen, HUANG Biao, PENG Haixia, WEI Xin, XU Weihong, SHENG Huiming, LI Ningli. Role of TRFIA for detecting pepsinogen in screening ulcer gastric cancer[J]. Laboratory Medicine, 2020, 35(7): 721-725.

图/表 6

参考文献 12

[1]	国家消化系统疾病临床医学研究中心,中华医学会消化内镜学分会,中华医学会健康管理学分会,等. 中国早期胃癌筛查流程专家共识意见(草案)(2017年,上海)[J]. 胃肠病学,2018,23(2):92-97.
[2]	卢旬,郑维玲,宋妙丽,等. 血清胃蛋白酶原、胃泌素17联合检测在健康体检中的应用价值[J]. 检验医学,2017,32(12):1095-1098.
[3]	LEE S P,LEE S Y,KIM J H,et al.Link between serum pepsinogen concentrations and upper gastrointestinal endoscopic findings[J]. J Korean Med Sci,2017,32(5):796-802.
[4]	BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
[5]	郑荣寿,孙可欣,张思维,等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志,2019,41(1):19-28.
[6]	陈中霞,纪璘,刘增超,等. 早期胃癌筛查现状及思考[J]. 中华消化内镜杂志,2019,36(5):305-309.
[7]	朱岚,黄飚,张珏,等. 不同人群胃蛋白酶原水平检测分析[J]. 中国公共卫生,2009,25(10):1216-1217.
[8]	HUANG B,XIAO H,ZHANG X,et al.Ultrasensitive detection of pepsinogen Ⅰ and pepsinogen Ⅱ by a time-resolved fluoroimmunoassay and its preliminary clinical applications[J]. Anal Chim Acta,2006,571(1):74-78.
[9]	赵缜,潘惠芬,曹国君. 胃蛋白酶原检测在非萎缩性胃炎和消化性溃疡患者中的应用[J]. 国际检验医学杂志,2016,37(9):1245-1247.
[10]	陈蕾,顾云峰,詹爱霞,等. 血清胃蛋白酶原在胃溃疡高危人群中的筛查价值[J]. 温州医科大学学报,2018,48(7):524-528.
[11]	费凤英,王金金,祝新华,等. 血清胃蛋白酶原检测在胃部疾病诊断中的意义[J]. 检验医学,2012,27(1):57-59.
[12]	国家消化系疾病临床医学研究中心(上海),国家消化道早癌防治中心联盟(GECA),中华医学会消化病学分会幽门螺杆菌学组,等. 中国幽门螺杆菌根除与胃癌防控的专家共识意见(2019年,上海)[J]. 中华消化杂志,2019,39(5):310-316.

方法	例数	PGⅠ/（ng/mL）	PGⅡ/（ng/mL）	PGR
TRFIA	447	152.40（109.60~227.70）	7.83（5.22~12.76）	19.60（15.00~24.80）
CMIA	447	51.70（36.70~77.40）	8.90（5.60~15.20）	6.20（4.59~7.53）

方法	例数	PGⅠ/（ng/mL）	PGⅡ/（ng/mL）	PGR
TRFIA	447	152.40（109.60~227.70）	7.83（5.22~12.76）	19.60（15.00~24.80）
CMIA	447	51.70（36.70~77.40）	8.90（5.60~15.20）	6.20（4.59~7.53）

项目	回归方程	a的95%CI	b的95%CI	r值
PGⅠ	Y_TRFIA=69.50+2.31X_CMIA	30.34~98.65	2.04~2.62	0.848
PGⅡ	Y_TRFIA=0.55+0.79X_CMIA	-0.28~1.63	0.74~0.83	0.964
PGR	Y_TRFIA=-2.47+3.93X_CMIA	-5.92~0.01	3.49~4.48	0.843

项目	回归方程	a的95%CI	b的95%CI	r值
PGⅠ	Y_TRFIA=69.50+2.31X_CMIA	30.34~98.65	2.04~2.62	0.848
PGⅡ	Y_TRFIA=0.55+0.79X_CMIA	-0.28~1.63	0.74~0.83	0.964
PGR	Y_TRFIA=-2.47+3.93X_CMIA	-5.92~0.01	3.49~4.48	0.843

组别	例数	PGⅠ/（ng/mL）	PGⅡ/（ng/mL）	PGR
消化性溃疡组	82	177.70（125.63~250.40）	10.17（6.66,14.47）	17.75（14.40~22.23）
胃癌组	104	142.00（81.55~201.25）^*	11.79（7.09~17.28）	13.06（6.37~18.07）^*
溃疡型胃癌组	43	158.00（85.60~205.00）	9.18（6.67~13.20）^*	15.97（10.23~20.43）^*
其他型胃癌组	61	136.00（89.60~195.50）^*	13.00（8.35~20.05）^#	10.06（5.11~17.44）^#